Received Jan 20, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 5J959 | — |
Patient may have received partial dose. Error could have been made where patient did not receive adjuvant with antigen. Risk Management completed analysis and consulted with Dr. with Infectious Disease. Patient will be offered repeat vaccination.